Sectoral Asset Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-42,714
Closed -$5.22M 141
2021
Q2
$5.22M Sell
42,714
-919
-2% -$143K 0.42% 85
2021
Q1
$8.05M Sell
43,633
-200
-0.5% -$47.4K 0.61% 63
2020
Q4
$12M Sell
43,833
-12,357
-22% -$3.11M 0.85% 44
2020
Q3
$13.2M Buy
+56,190
New +$14.1M 1.13% 36

Other funds holding FRLN

Sectoral Asset Management's FRLN Position: Q3 2021 in Review

Sectoral Asset Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2021, closing a stake of 42,714 shares — an estimated $5.22M sold.

Sectoral Asset Management first reported a position in FRLN in Q3 2020 and held it in 4 quarters. The position peaked at $13.2M in Q3 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q3 2021.

  • Sectoral Asset Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Sectoral Asset Management sold 42,714 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2021, an estimated $5.22M.
  • Sectoral Asset Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 4 quarters.
  • Sectoral Asset Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $13.2M in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2021.

Based on Sectoral Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.